MaxwellM.H., RockneyR.E., KleemanC.R., and TwissM.R.: Peritoneal Dialysis 1. Technique and Applications.J. Amer. Med. Assoc.170: 91–98, 1959.
2.
YutucW., WardG., ShilipetarG., and TepckhoffH.: Substitution of sorbitol for dextrose in peritoneal irrigation fluid: A preliminary report.Trans. Amer. Soc. Artif. Int. Organs13: 168–171, 1967.
3.
RajaR.M., KramerM.S., ManchandaR., LazaroN., and RosenbaumI.L.: Peritoneal dialysis with fructose dialysate prevention of hyperglycemia and hyperosmolality.Ann. Intern. Med.79: 511–517. 1973.
4.
GjessingI.: The use of dextran as a dialyzing fluid in peritoneal dialysis.Acta. Med. Scand.185: 237–239. 1969.
5.
OreopoulosD.G., BalfeI.W., KhannaR., CrasswellerP., GotloibL., RodellaH., ZellennanG., BrandesL., McCreadyW., OgilvieR., and HusdanH.: Further experience with the use of amino acid containing dialysate (arnino-dianeal) in peritoneal dialysis. In CAPD Update (MoncriefI.W., and PopovitchR.P. Eds), Masson PublishingNew York, 1981. p 109–115.
6.
RajaR.M., CantorR.E., BoreykoC., BushehriH., KramerM.S., and RosenbaumI.L.: Sodium transport during ultrafiltration peritoneal dialysis.Trans. Amer. Soc. Artif. Int. Organs18: 429–435, 1972.
7.
AhearnD.J., and NolphK.D.: Controlled sodium removal with peritoneal dialysis.Trans. Amer. Soc. Artif. Int. Organs18: 423–428, 1972.
8.
AbrutynE., GoodhartG.L., RoosK., AndersonR., and BuxtonA.: Acineto bacter calcoaceticus outbreak associated with peritoneal dialysis.Amer. J. Epidemiol.107: 328–335, 1978.
9.
MaderI.T., and ReinarzI.A.: Peritonitis during peritoneal dialysis -the role of the preheating water bath.J. Chron. Dis.31: 635–641, 1978.
10.
GaunterW.C., FeldmanH.A., and PuschettI.B.: Peritonitis in chronic peritoneal dialysis patients.Clin. Nephrol.13: 255–259, 1980.
11.
AshlineV., StevensA., and CarterM.I.: Nosocomial peritonitis related to contaminated dialysate warming water.Amer. J. Infect. Control9: 50–52, 1981.
12.
Data collected from Lankenau Hospital, Philadelphia, PA (Contract consultants).
13.
McDonaldH.P.: An automatic peritoneal dialysis machine for hospital or home peritoneal dialysis: Preliminary report.Trans. Amer. Soc. Artif. Int. Organs15: 108–113, 1969.
14.
LaskerN., BurkerI.F., PatchefskyA., and HaugheyE.: Peritoneal reactions to particulate matter in peritoneal dialysis solutions.Trans. Amer. Soc. Artif. Int. Organs21: 342–345. 1975.
15.
KaranicolasS., OreopoulosD.G., LzattS.H., ShimizuA., ManningR.F., SeppH., DeVeberG.A., and DarbyT.: Epidemic of aseptic peritonitis caused by endotoxin during chronic peritoneal dialysis.New Engl. J. Med.296: 1336–1337, 1977.
16.
Data collected from Nalle Clinic Kidney Center and Charlotte Memorial Hospital, Charlotte. NC (Contract consultants).
17.
Data collected from Regional Kidney Disease Program. Minneapolis, MN (Contract consultants).
18.
SchmidtR.W., and BlumenkrantzM.: Peritoneal sclerosis: A ‘sword of Democles’ for peritoneal dialysis?Arch. Intern Med.141: 1265–1267. 1981.
19.
Investigation of the Risks and Hazards Associated with Hemodialysis Devices.Food and Drug Administration, Department of Health. Education and Welfare, 1980. p 12–74. (Available from National Technical Infonnation Service, 5285 Port Royal Road. Springfield, V A 22161. Report No. PB-80-215403.)
20.
American National Standard for Hemodialysis Systems.ANSI/AAMI RD5.Association for the Advancement of Medical InstrumentationArlingt On, Virginia, 1981.
21.
ThomsonN.M., StevensB.I., HumpheryT.I., and AtkinsR.C.: Trace elements in patients on continuous ambulatory peritoneal dialysis. In Advances in Peritoneal Dialysis (GahlG.M., KesselM., and NolphK.D. Eds) Excerpta MedicaAmsterdam1981, p 473–477.
22.
GokalR., ParkinsonI.S., RamosM., WardM.K., and KerrD.N.S.: Elevated serum aluminum levels in patients on continuous ambulatory peritoneal dialysis. In Advances in Peritoneal Dialysis (GahlG.M., KesselM., and NolphK.D., Eds) Excerpta MedicaAmsterdam1981. p 478–482.
23.
SorkinM.I., NolphK.D., AndersonH.O., MorrisI.S., KennedyI., ProwantB., and MooreH.: Aluminum mass transfer during continuous ambulatory peritoneal dialysis.Peritoneal Dialysis BulletinI: 91–93, 1981.
24.
CummingA.D., SimpsonG., BellD., CowieI., and WinneyR.I.: Acute aluminum intoxication in patients on continuous ambulatory peritoneal dialysis.LancetI: 103–104. 1982.
25.
OreopoulosD.G., ClaytonS., DombrosN., ZellennanG., and KatirtzoglouA.: Nineteen months experience with continuous ambulatory peritoneal dialysis (CAPD).Proc. Europ. Transpl. Assoc.16: 178–183. 1979.
26.
NolphK.D., SorkinM., Rubinl, ArfaniaD., ProwantB., FrutoL., and KennedyD.: Continuous ambulatory peritoneal dialysis: Three-year experience at one center.Ann. Intern. Med.92: 609–613, 1980.
27.
LackeC., SenekjianH.O., KnightT.F., FrazierM., HatelidR., KozakM., BakerP., and WeinmanEl: Twelve months’ experience with continuous ambulatory and intennittent peritoneal dialysis.Arch. Intern. Med.141: 187–190, 1981.
28.
RubinI., OreopoulosD.G., BlairR.D.G., ChisholmL.D.I., MeemaH.E., and DeVeberG.A.: Chronic peritoneal dialysis in the management of diabetes with tenninal renal failure.Nephron19: 265–270, 1977.
29.
FlynnC.T., and NansonI.A.: Intraperitoneal insulin with CAPD -an artificial pancreas.Trans. Amer. Soc. Artif. Intern. Organs25: 114–117, 1979.
30.
TrioloG., SegoloniG., CartaQ., Boggio-BertinetD., AlloattiS., StrattaP., MessinaM., PriascaG., and VercelloneA.: CAPD with intrabag insulin administration (IBIA): An easy strategy to improve the uremic diabetic patient (UDP) management. In Advances in Peritoneal Dialysis (GahlG.M., KesselM., and NolphK.D., Eds) Excerpta MedicaAmsterdam1981, p 424–426.
31.
AmidonG., ReighertI.E., and JohnsonC.A.: Adsorption of insulin to the polyvinyl chloride surface of CAPD solution containers.Proc. Clin. Dial. Transpl. Forum10: 296–298, 1980.
32.
BoyerI., GillG.N., and EpsteinF.H.: Hyperglycemia and hyperosmolality complicating peritoneal dialysis.Ann. Intern. Med.67: 568–572. 1967.
33.
HandaS.P., and CushnerG.B.: Hyperosmolar hyperglycemic nonketotic coma during peritoneal dialysis.Southern Med. J.61: 700–702, 1968.
34.
GaultM.H., FergusonE.L., SidhuI.S., and CorbinR.P.: Fluid and electrolyte complications of peritoneal dialysis. Choice of dialysis solutions.Ann. Intern. Med.75: 253–262, 1971.
35.
VidtD.G.: Recommendations on choice of peritoneal dialysis solutions.Ann. Intern. Med.78: 144–146, 1973.
36.
HalabyS.F., and MattocksA.M.: Absorption of sodium bisulfite from peritoneal dialysis solutions.J. Pharm. Sci.54: 52–55, 1965.
37.
RajaR.M., MorosI.G., KramerM.S., and RosenbaumI.L.: Hyperosmotic coma complicating peritoneal dialysis with sorbitol dialysate.Ann. Intern. Med.73: 993–994, 1970.
38.
BischelM.D., and BarbourB.H.: Peritoneal dialysis with sorbitol versus dextrose dialysate.Nephron12: 449–463. 1974.
39.
QuellhorstU.A., MietzschG., DohtB., Femandez-RedoE., KuboschI., LeititisU., VollesE., ThorwortV., and SchelerF.: Sorbithaltige Spullosung aIs Ursache schwerer Unvertraglichkeitserscheinungen bei der Peritonealdialyse.Dtsch. Med. Wochenschr100: 1431–1435, 1975.
40.
Food and Drug Administration, Device Experience Network Reports #33000. 1978 and #36269, 1980.
41.
BissonP.G., and BaileyK.M.: Sodium in peritoneal dialysis solutions.Brit. Med. J.5: 1322–1324, 1979.
42.
EbbenI., DavinT., and KjellstrandC.: Volume and Chemical Errors in Peritoneal Dialysate.Dial. Transplant10: 876, 1981.
43.
KoppV.H., and TonnisH.I.: The effect of temperature on the effectiveness of peritoneal dialysis.Munch. Med. Wo - chenschr.109: 2438–2443, 1967.
RahnerE.: Hohes Hepatitis-Infektionsrisiko fur das personal bei der peritonealdialyse be handlung Australiaantigen positiver patienten.Med. Welt25: 1705–1707, 1974.
46.
SpectorD.: Hepatitis B miniepidemic in a peritoneal dialysis unit.Arch. Intern. Med.137: 1030–1031, 1977.
47.
BondW.W., PetersenN.I., GravelleC.R., and FaveroM.S.: Hepatitis B virus in peritoneal dialysis fluid: A potential hazard.Dial. Transplant.II: 592–600, 1982.
48.
GoodmanW., GallagherN., and SherrardDl: Peritoneal dialysis fluid as a source of hepatitis antigen.Nephron29: 107–109, 1981.
49.
Phannaceutical Codex, Ilth Edition, Phannaceutical Society of Great BritainLondon, 1979, p 265.
50.
Code of Federal Regulations. Title 21, Section 310, Paragraph 310.509, Parenteral drug products in plastic containers.
51.
RabinowB.: Contribution of the trace metal contaminants in the dialysis concentrate to dialyzing fluid. In Issues in Hemodialysis: Systems Performance, Water Purity and Treatment Cost Reimbursement and Regulation.Association for the Advancement of Medical InstrumentationArlington, Virginia1981, p 34–40.
52.
The United States Phannacopeia, 20th Revision, United States Phannacopeial Convention, Rockville. MD, 1980, p 950–953.